Billions of people still suffer from every-day diseases.
One key reason? Clinical trials are broken.
Despite $120 billion spent each year, most trials are delayed due to bottlenecks like patient recruitment.
Delfa is fixing this with autonomous AI agents. We're building AI agents to automate clinical trials, starting with patient recruitment.
Just three months in and already we’re:
Live on 30+ trials across multiple conditions
Mid-six-figure revenue and rising
300 % MoM product growth
$3.8 m seed from tier-one AI investors Air Street Capital
